Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion

Fig. 2

EGFR mutation and infiltration of CD39 + CD8 + T cell population in MPE of LUAD. A The accumulation of CD39 + CD8 + T cells in MPE was selectively elevated in LUAD with EGFRwt (18.85 ± 3.53%, n = 28, P = 0.04) and EGFR-TKI acquired resistance (AR-EGFR-TKI) (19.43 ± 4.26%, n = 19, P = 0.04), compared with firstly-diagnosed EGFRmu (4.24 ± 2.39%, n = 12). B Prediction of the frequency of pleural CD39 + CD8 + T cells indicating the occurrence of EGFR mutation in LUAD-related MPE. The AUC was 0.78 (P < 0.01) with a sensitivity and specificity of 83.33% and 71.40% when the cut-off value was 4.94%

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us